saponin/悪性腫瘍

This application is a 371 of PCT/KR2006/003668 filed on Sep. 14, 2006, published on Apr. 5, 2007 under publication number WO 2007/037598 A1 which claims priority benefits from South Korean Patent Application Number 10-2005-0091442 filed Sep. 29, 2005, the disclosure of which is hereby incorporated

BACKGROUND OF THE INVENTION Tumor-specific antigens have been identified and pursued as targets for vaccines. Previous work from the inventors' has shown that monovalent vaccines utilizing the tumor antigens Globo H, Lewis.sup.y, GM2, glycosylated MUC-1, Tn(c), sTn(c), or TF(c) conjugated to KLH to

Throughout this application, various references are referred to. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains. BACKGROUND OF THE INVENTION Tumor-specific

BACKGROUND OF THE INVENTION Tumor-specific antigens have been identified and pursued as targets for vaccines. Previous work from the inventors' has shown that monovalent vaccines utilizing the tumor antigens Globo H, Lewis.sup.y, GM2, glycosylated MUC-1, Tn(c), sTn(c), or TF(c) conjugated to KLH to

Throughout this application, various references are referred to. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains. BACKGROUND OF THE INVENTION Tumor-specific

Throughout this application, various references are referred to. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains. BACKGROUND OF THE INVENTION Tumor-specific

1. FIELD OF THE INVENTION The present invention relates to pharmaceutical compositions that are useful for the prevention and treatment of infectious diseases, primary and metastatic neoplastic diseases (i.e., cancer), neurodegenerative or amyloid diseases, or any other disease wherein the treatment

FIELD OF THE INVENTION This invention relates to saponins, and compounds with angeloyl groups isolated from plants, their uses and functions, and methods of their preparations. SUMMARY OF THE INVENTION In accordance with these and other objects of the invention, a brief summary of the present

Throughout this application, various publications are referenced. Disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to which this invention pertains. FIELD OF THE INVENTION This

BACKGROUND OF THE INVENTION Cancer vaccines are designed to treat cancers by boosting the body's natural ability to protect itself, through the immune system. It has always represented a very attractive therapeutic approach, especially in light of the many shortcomings of conventional surgery,

BACKGROUND OF THE INVENTION The present invention relates to the field of therapeutic compounds for the treatment of diseases of the skin. In particular the present invention relates to creams made from the herb Tribulus Terrestris which are useful in the treatment of vulvo-vaginitis,

This invention relates to compositions extracted from vegetable matter and more particularly to phytochemicals, including saponogenins and saponins, catechins, lignans, phenolic acids, and isoflavones, and especially those extracted from a family of plants including soy, flax, tea, and cocoa, and

This invention relates to compositions extracted from vegetable matter and more particularly to phytochemicals, including saponogenins and saponins, lignans, phenolic acids, catechins and isoflavones, and especially those extracted from a family of plants including soy, flax, tea, and cocoa and

CROSS REFERENCE TO RELATED APPLICATION The present application is the U.S. national stage of International Application PCT/SE2014/050380, filed Mar. 31, 2014, which international application was published on Oct. 9, 2014, as International Publication No, WO2014/163558. The International Application

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is in the field of adjuvants and immunostimulating agents. More particularly, the invention pertains to vaccines and immunostimulating compositions that include saponin-lipophile conjugate adjuvants. 2. Related Art Saponins